Identification of Fusion Transcripts in Leukеmic Cells by Whole-Transcriptome Sequencing
- Authors: Ikonnikova A.Y.1, Ammour Y.I.2, Snezhkina A.V.1, Krasnov G.S.1, Kudryavtseva A.V.1, Nasedkina T.V.1,2
-
Affiliations:
- Engelhardt Institute of Molecular Biology
- Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
- Issue: Vol 52, No 2 (2018)
- Pages: 200-205
- Section: Genomics. Transcriptomics
- URL: https://journal-vniispk.ru/0026-8933/article/view/163457
- DOI: https://doi.org/10.1134/S0026893318020048
- ID: 163457
Cite item
Abstract
Genetic aberrations in leukemia often lead to the formation of expressed chimeric genes, which should be assessed for proper diagnosis and therapy. Modern methods of molecular diagnostic mainly allow to identify already known fusion genes. RNAseq is an efficient tool for identification of rare and novel chimeric transcripts. Here we present the results of the whole transcriptome analysis of bone marrow samples from five patients with acute myeloblastic leukemia and one, with myelodysplastic syndrome. The wholetranscriptome analysis was performed using Illumina/Solexa approach. We found rare or unknown chimeric transcripts including ETV6-MDS1, MN1-ETV6, OAZ1-PTMA, and MLLT10-GRIA4. Each of these transcripts was confirmed by RT-PCR and Sanger sequencing.
About the authors
A. Yu. Ikonnikova
Engelhardt Institute of Molecular Biology
Email: nased@biochip.ru
Russian Federation, Moscow, 119991
Yu. I. Ammour
Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
Email: nased@biochip.ru
Russian Federation, Moscow, 119117
A. V. Snezhkina
Engelhardt Institute of Molecular Biology
Email: nased@biochip.ru
Russian Federation, Moscow, 119991
G. S. Krasnov
Engelhardt Institute of Molecular Biology
Email: nased@biochip.ru
Russian Federation, Moscow, 119991
A. V. Kudryavtseva
Engelhardt Institute of Molecular Biology
Email: nased@biochip.ru
Russian Federation, Moscow, 119991
T. V. Nasedkina
Engelhardt Institute of Molecular Biology; Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
Author for correspondence.
Email: nased@biochip.ru
Russian Federation, Moscow, 119991; Moscow, 119117
Supplementary files
